{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-019500","form_type":"8-K","ticker":null,"cik":"0001642375","company_name":"Guardion Health Sciences, Inc.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.797433+00:00","generated_at":"2026-06-14T11:44:46.563990+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Guardion Health Sciences appoints Jan Hall as CEO; Bret Scholtes resigns effective June 9, 2023","bullets":["Bret Scholtes resigns as President, CEO, and director effective June 9, 2023; no disagreement with company.","Jan Hall appointed President and CEO effective June 19, 2023; former Neutrogena North America President and Coca-Cola SVP.","Hall's employment: $370,000 base salary, target bonus up to 100% of base, severance up to 12 months.","Board reduced from five to four directors effective June 10, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-019500","json":"https://secwatch.observer/filing/0001493152-23-019500.json","markdown":"https://secwatch.observer/filing/0001493152-23-019500.md","text":"https://secwatch.observer/filing/0001493152-23-019500.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:44:46.563990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9caa848132","claim":"Bret Scholtes resigned as President and Chief Executive Officer at Guardion Health Sciences, Inc..","evidence_excerpt":"accepted the resignation of Bret Scholtes, the Company’s President and Chief Executive Officer, effective as of June 9, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"f677b6ec8b","claim":"Janet Hall was appointed as President and Chief Executive Officer at Guardion Health Sciences, Inc..","evidence_excerpt":"Effective as of June 19, 2023, the Company appointed Janet (“Jan”) Hall as the Company’s President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}